The Evolving Regulatory Landscape for Clinical Trials in India
Food and Drug Law Journal | Volume 73 | Number 4
How Might Manufacturers of E-Cigarettes Get New Product and MRTP Orders from FDA More Quickly and Easily?
Food and Drug Law Journal | Volume 73 | Number 4
The Responsible Corporate Officer Doctrine: Protections are Needed Despite DOJ’s Cautious Approach GalleryThe Responsible Corporate Officer Doctrine: Protections are Needed Despite DOJ’s Cautious Approach
Archived Publication, Drugs, Medical Devices, Biologics, Food, Dietary Supplements, Cosmetics, Interest, Publications, Tobacco Products, Update December 2018/January 2019, Update Magazine
The Responsible Corporate Officer Doctrine: Protections are Needed Despite DOJ’s Cautious Approach
Update Magazine | December 2018/January 2019
JUUL in Schools: Can FDA Close the Youth On-Ramp While Still Maintaining the Off-Ramp for Adult Smokers? GalleryJUUL in Schools: Can FDA Close the Youth On-Ramp While Still Maintaining the Off-Ramp for Adult Smokers?
Archived Publication, Interest, Publications, Tobacco Products, Update December 2018/January 2019, Update Magazine
JUUL in Schools: Can FDA Close the Youth On-Ramp While Still Maintaining the Off-Ramp for Adult Smokers?
Update Magazine | December 2018/January 2019
The Criminalization of Dietary Supplement Enforcement
Update Magazine | December 2018/January 2019
Un-“Stacking” Class Actions
Update Magazine | December 2018/January 2019
A Storm Is Brewing: What Happened to the Generic Pharmaceutical Anti-Trust Price Fixing Criminal Investigation? GalleryA Storm Is Brewing: What Happened to the Generic Pharmaceutical Anti-Trust Price Fixing Criminal Investigation?
Archived Publication, Drugs, Medical Devices, Biologics, Interest, Publications, Update December 2018/January 2019, Update Magazine
A Storm Is Brewing: What Happened to the Generic Pharmaceutical Anti-Trust Price Fixing Criminal Investigation?
Update Magazine | December 2018/January 2019
Gene Therapy – FDA Takes Steps Toward Clarifying Scope of Orphan Drug Exclusivity GalleryGene Therapy – FDA Takes Steps Toward Clarifying Scope of Orphan Drug Exclusivity
Archived Publication, Drugs, Medical Devices, Biologics, Interest, Publications, Update December 2018/January 2019, Update Magazine
Gene Therapy – FDA Takes Steps Toward Clarifying Scope of Orphan Drug Exclusivity
Update Magazine | December 2018/January 2019
FDA’s New Pilot Program Encouraging Innovation
Update Magazine | December 2018/January 2019
Patient Organizations: An Introduction to Drug Law and Regulation
November 7–8, 2018 I Washington, DC
For non-profit professionals only
